Imaging Diagnostics Systems' CT laser mammo gets closer to US
This article was originally published in Clinica
Executive Summary
Imaging Diagnostics Systems' (IDS) CT laser mammography (CTLM) system is edging closer to the US market, the company told Clinica, after enrolling a tenth site in clinical trials of the technology. Results of the study will be used in its premarket approval (PMA) application to the US FDA. The Fort Lauderdale, Florida company may add two further sites to the trial to "further shorten the time" needed to collect enough patient data to submit for approval.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.